During this program, learners will increase their knowledge in the management of congenital adrenal hyperplasia (CAH) by familiarizing themselves with emerging treatments and new safety and efficacy data. Participants will have greater competence related to the unmet needs in managing classic CAH in adult patients, mechanisms of action and clinical data of new and emerging therapies for CAH, applying this data to select treatments, and identifying potential places in therapy of emerging agents.
- Provider:Endocrine Society
- Activity Link: https://education.endocrine.org/URL/ENDO24_CAH_Enduring
- Start Date: 2024-07-24 05:00:00
- End Date: 2024-07-24 05:00:00
- Credit Details: AMA PRA Category 1 Credit™️: 1.0 hours
- MOC Credit Details: ABIM - 1.0 Point; Credit Type(s): Medical Knowledge (ABIM)
- Commercial Support: Source: Neurocrine Biosciences - Amount: 430000.0 - Is Kind Support: False
- Activity Type: Enduring Material
- CME Finder Type: Online Learning
- Fee to Participate: No, it's free
- Measured Outcome: Learner Competence, Learner Knowledge, Learner Performance
- Provider Ship: Directly Provided
- Registration: Open to all
- Specialty: Endocrinology, Diabetes, and Metabolism
Subscribe
Login
0 Comments
Oldest